Fifteen Canadian startups are selected to participate in the Metabridge program each year. This program aims to “accelerate the best & brightest high growth technology Start-ups in Canada.” Aspect Biosystems is proud to be voted Metabridge’s Most Promising Startup of 2017. Read full press release here.
Aspect Media Coverage
April 27, 2017 | Bloomberg Businessweek | “We’re Getting Closer to Mass Production of Bones, Organs and Implants”
A record amount of money is spent developing new drugs, but drug approval rates are declining and many fatal diseases are left untreated. A big reason behind this is often times current drug testing methods including animal testing don’t accurately predict the human response to drugs. What if we can 3D print living human tissue […]
VANCOUVER, BC, Canada – March 15, 2017 – Aspect Biosystems Ltd., a leader in the field of 3D bioprinting and tissue engineering, is pleased to announce a research collaboration with University of Manitoba Professor Adrian West. The research collaboration is supported by the Canada Foundation for Innovation’s (CFI) John R. Evans Leaders Fund (JELF). The […]
March 13, 2017 | Global News BC | “A B.C. company is using 3-D printing to create human tissue for testing life-saving drugs, and has its sights set even higher in the future. Linda Aylesworth reports.” Watch the feature here.
March 3, 2017 | Ready to Rocket | Aspect Biosystems has been selected for Ready to Rocket’s Life Sciences List 2017. Ready to Rocket highlights British Columbia technology companies with high growth potential in the life sciences, digital health, cleantech and ICT sectors. This is Aspect’s third year on the list. See full press release here.